Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode (TM) Whole ...
Researchers developed a new RNA sequencing strategy that can reveal how genetic variants disrupt gene function and improve the diagnosis of rare diseases. The study team demonstrated that this ...
BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study in collaboration with The University of Texas MD Anderson Cancer Center, ...
Complete the form below to access this White Paper, which explores how to sequence full-length cDNA and native RNA with Oxford Nanopore sequencing. Legacy sequencing technologies have made ...
New Trailmaker functionality integrates immune repertoire and whole transcriptome data to deliver rapid, publication-ready insights Parse Biosciences, the leading provider of accessible and scalable ...
What makes a chili pepper spicy, colorful, and full of flavor? Scientists have now decoded the genetic journey behind pepper development, using long-read sequencing to build the most comprehensive ...
Immunotherapy has been a revolutionary breakthrough for cancer therapeutics, but it is still hampered in that it only benefits certain patients. Moreover, the molecular determinants of immunotherapy ...
Clinical significance of c-Met expression in patients with advanced gastroesophageal adenocarcinoma. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers Symposium. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results